San Francisco / Washington / DC / Los Angeles / Chicago / /
Company
AMGEN INC. AND HOFFMANN-LA ROCHE INC. / Amgen Inc. / Caraco Pharm / Nucleonics Inc. / BACKGROUND Amgen / MedImmune Inc. / Integra Lifesciences I Ltd. / 3M Co. / Merck KGaA / Medtronic Inc. / Arkema Inc. / 2 SANDOZ INC. / SANDOZ INC. / Skelly Oil Co. / Medicis Pharm / Mirowski Family Ventures LLC / etaner- SANDOZ INC. / Hoffman-La Roche Inc. / Ventritex Inc. / Sidley Austin LLP / TubeMaster Inc. / Honeywell / Avery Dennison Corp. / Prasco LLC / Genentech Inc. / Phillips Petroleum Co. / HURST / Winston & Strawn LLP / F. Hoffman-LaRoche Ltd. / Cat Tech LLC / Immunex / /
Country
United States / /
Event
FDA Phase / Legal Issues / Business Partnership / /
Facility
United States District Court / /
IndustryTerm
biological products / drug product / reference product / etanercept product / biological product / contemplated etanercept product / pharmaceutical compositions / similar situation involving medical-device manufacturer / product / federal law / accused medical device / /
MedicalCondition
human tumor necrosis / rheumatoid arthritis / injury / future injury / real and immediate injury / /
Organization
United States District Court for the Northern District of California / Food and Drug Administration / Patent and Trademark Office / Supreme Court / United States Court of Appeals / Congress / US Federal Reserve / /
Person
SAMUEL N. TIU / JAMES M. HILMERT / Nat / DAVID T. PRITIKIN / MAUREEN L. RURKA / Maxine M. Chesney / M. PATRICIA THAYER / JEFFREY P. KUSHAN / J. DREW DIAMOND / GAIL A. KATZ / JAMES A. HIGH / JR. / VERNON M. WINTERS / WENDY A. WHITEFORD / /